National Survey on Coronary Patients and Heart Failure Performed in 2 Patient Groups
Comparison and Description of Coronary Patients Management With or Without Heart Failure in Cardiology Consulting
Sponsor: AstraZeneca
Listed as NCT00699959, this observational or N/A phase trial focuses on Coronary Patients and Heart Failure and remains completed. Sponsored by AstraZeneca, it has been updated 7 times since 2008, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
7 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2021 — Jul 2024 [monthly]
Completed
-
Jun 2018 — Jan 2021 [monthly]
Completed
▶ Show 2 earlier versions
-
Apr 2018 — Jun 2018 [monthly]
Completed
Phase: NA → None
-
Jan 2017 — Apr 2018 [monthly]
Completed NA
First recorded
Jun 2008
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- AstraZeneca
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Abbeville, France , Aix-en-Provence, France , Aix-les-Bains, France , Ajaccio, France , Albi, France , Alençon, France , Alès, France , Amboise, France , Amiens, France , Andrézieux-Bouthéon, France and 314 more locations